|
|
Efficiency of nilotinib to target chronic phase-chronic myeloid leukaemia primary mature CD34− and immature CD34+ cells
Marc Berger
,
Benjamin Lebecque
,
Thomas Tassin
,
Louis-Thomas Dannus
,
Juliette Berger
et al.
Journal articles
hal-03278034v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome
Erin Parry
,
Ignaty Leshchiner
,
Romain Guièze
,
Connor Johnson
,
Eugen Tausch
et al.
Journal articles
hal-03950358v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Réforme de l’accès dérogatoire aux médicaments
Jacques-Olivier Bay
Journal articles
hal-03737555v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Splenectomy before allogeneic hematopoietic cell transplantation for myelofibrosis: A French nationwide study
Jean‐baptiste Bossard
,
Jean‐baptiste Beuscart
,
Marie Robin
,
Mohamad Mohty
,
Fiorenza Barraco
et al.
Journal articles
hal-03089653v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Characterization of the novel HLA‐B *56:76 allele by sequencing‐based typing
Lucie Blandin
,
Jonathan Visentin
,
Gwendaline Guidicelli
,
Paul Rouzaire
,
Richard Lemal
et al.
Journal articles
hal-03449232v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Round table : impact of CAR T-cells on patient journey, local or regional organization, and follow-up
Jacques-Olivier Bay
Cell Therapy Innovation 360°, May 2019, Lyon, France
Conference papers
hal-02056276v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Accuracy of Chitotriosidase Activity and CCL18 Concentration in Assessing Type I Gaucher Disease Severity. A Systematic Review with Meta-analysis of Individual Participant Data
Tatiana Raskovalova
,
Patrick B. Deegan
,
Pramod K. Mistry
,
Elena Pavlova
,
Ruby Yang
et al.
13th EWGGD Meeting, Jul 2019, Clermont-Ferrand, France
Conference poster
hal-02304018v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Traitement de première ligne de la Leucémie Myéloïde Chronique dans la « vraie vie » : Données de l’Observatoire LMC
Alexandre Janel
,
Sandrine Saugues
,
C. Lambert
,
Hyacinthe Johnson-Ansah
,
Denis Guyotat
et al.
39e Congrès de la Société Française d’Hématologie, Mar 2019, Paris, France. 25 (S1), pp.172, 2019, Hématologie
Conference poster
hal-02304921v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Arrêt des Inhibiteurs de Tyrosine Kinase (ITK) pour réponse optimale dans la LMC dans la « vraie vie » et recommandations du groupe Fi-LMC
Alexandre Janel
,
Sandrine Saugues
,
C. Lambert
,
Hyacinthe Johnson-Ansah
,
Denis Guyotat
et al.
39e Congrès de la Société Française d’Hématologie, Mar 2019, Paris, France. 25 (S1), pp.173, 2019, Hématologie
Conference poster
hal-02304953v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Real-World Ibrutinib Validation of the Ball Score to Predict Overall Survival: A Filo Group Study in RR CLL Patients
Loic Ysebaert
,
A.S. Michallet
,
F. Bijou
,
A. Clavert
,
A. Quinquenel
et al.
61st Annual Meeting and Exposition of the American Society of Hematology, Dec 2019, Orlando, United States. 134 (Suppl 1), pp.1741, 2019, Blood
Conference poster
hal-02427548v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Gray-zone Lymphoma Between cHL and Large B-Cell Lymphoma
Clémentine Sarkozy
,
Christiane Copie-Bergman
,
Diane Damotte
,
Susana Ben-Neriah
,
Barbara Burroni
et al.
Journal articles
hal-02055918v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Human herpesvirus 6 infection after autologous stem cell transplantation: A multicenter prospective study in adult patients
Marie Balsat
,
Sylvie Pillet
,
Emmanuelle Tavernier
,
Victoria Cacheux
,
Vanessa Escuret
et al.
Journal articles
hal-02299171v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Quelle place pour l’allogreffe à l’ère des nouvelles drogues et des nouvelles approches d’immunothérapie dans les hémopathies malignes ? (SFGM-TC)
Jacques-Olivier Bay
39e Congrès de la Société Française d’Hématologie, Mar 2019, Paris, France
Conference papers
hal-02124755v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease
M. Biegstraaten
,
M. Cox
,
N. Belmatoug
,
M.G Berger
,
T. Collin-Histed
et al.
Journal articles
hal-01672894v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Les points chauds de l’actualité en 2017. Une sélection du comité de rédaction du Bulletin du Cancer
Stéphane Vignot
,
Thierry André
,
Christophe Caux
,
Carole Bouleuc
,
Serge Evrard
et al.
Journal articles
hal-01712424v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Consolidation anti-CD22 fractionated radioimmunotherapy with 90 Y-epratuzumab tetraxetan following R-CHOP in elderly patients with diffuse large B-cell lymphoma: a prospective, single group, phase 2 trial
Francoise Kraeber-Bodere
,
Amandine Pallardy
,
Hervé Maisonneuve
,
Loïc Campion
,
Anne Moreau
et al.
Journal articles
hal-02425339v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Effect of Azithromycin on Airflow Decline–Free Survival After Allogeneic Hematopoietic Stem Cell Transplant
Anne Bergeron
,
Sylvie Chevret
,
Angela Granata
,
Patrice Chevallier
,
Laure Vincent
et al.
Journal articles
hal-01655930v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Ibrutinib in very elderly patients with relapsed/refractory chronic lymphocytic leukemia: A real-world experience of 71 patients treated in France: A study from the French Innovative Leukemia Organization (FILO) group
Sophie Michallet
,
Arnaud Campidelli
,
Helene Lequeu
,
Marie-Sarah Dilhuydy
,
Olivier Tournilhac
et al.
Journal articles
hal-01653723v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Plasma chitotriosidase activity versus CCL18 level for assessing type I Gaucher disease severity: protocol for a systematic review with meta-analysis of individual participant data
Tatiana Raskovalova
,
Patrick B. Deegan
,
Ruby Yang
,
Elena Pavlova
,
Jérôme Stirnemann
et al.
Journal articles
hal-01655857v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Intra-monocyte Pharmacokinetics of Imiglucerase Supports a Possible Personalized Management of Gaucher Disease Type 1
Juliette Berger
,
Marie Vigan
,
Bruno Pereira
,
Thu Thuy Nguyen
,
Roseline Froissart
et al.
Journal articles
hal-02052295v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Long-term outcomes of adults with first-relapsed/refractory systemic anaplastic large-cell lymphoma in the pre-brentuximab vedotin era: A LYSA/SFGM-TC study
Alexandre Morel
,
Josette Brière
,
Laurence Lamant
,
Michael Loschi
,
Corinne Haioun
et al.
Journal articles
hal-01655967v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate-risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006-intermediate-risk trial
Anne Bouvier
,
Jean-Francois Hamel
,
Jacques Delaunay
,
Eric Delabesse
,
Pierre-Yves Dumas
et al.
Journal articles
hal-03604930v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
DNA Methylation and Intra-Clonal Heterogeneity: The Chronic Myeloid Leukemia Model
Benjamin Lebecque
,
Céline Bourgne
,
Véronique Vidal
,
Marc Berger
Journal articles
hal-03440088v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Characterization of the novel HLA‐DQA1 *01:39 allele by next‐generation sequencing
Steve Genebrier
,
Paul Rouzaire
,
Emeric Texeraud
,
Gerald Bertrand
,
Virginie Renac
et al.
Journal articles
hal-03449390v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Characterization of the novel HLA‐C *06:311 allele by sequencing‐based typing
Lucie Blandin
,
Mamy Ralazamahaleo
,
Marine Cargou
,
Richard Lemal
,
Paul Rouzaire
et al.
Journal articles
hal-03449287v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
ZNF683 (Hobit) Marks a CD8+ T Cell Population Associated with Anti-Tumor Immunity Following Anti-PD-1 Therapy for Richter Syndrome
Camilla Lemvigh
,
Erin Michelle Parry
,
Stephanie Deng
,
Nathan Dangle
,
Neil Ruthen
et al.
Journal articles
hal-03950370v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Outcome and impact of post-remission strategy after MIDAM regimen in patients with relapsing or refractory acute myeloid leukemia
Salem Bahashwan
,
Cécile Moluçon-Chabrot
,
Eric Hermet
,
Aurélie Ravinet
,
Aurore Douge
et al.
Journal articles
hal-01926811v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Maladie de Gaucher
Marc Berger
4èmes Journées d’Hématologie Biologique du Grand-Est, Mar 2019, Nancy, France
Conference papers
hal-02125901v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Contribution of Chronic Myeloid Leukaemia (CML) as a Disease Model to Define and Study Clonal Heterogeneity
Marc Berger
,
Céline Bourgne
Book sections
hal-02301455v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Development of a disease-specific graded prognostic assessment index for the management of sarcoma patients with brain metastases (Sarcoma-GPA)
Anna Patrikidou
,
Loïc Chaigneau
,
Nicolas Isambert
,
Kyriaki Kitikidou
,
Ryan Shanley
et al.
Journal articles
hal-02872774v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|